3 Biotech Stocks with Explosive Growth Potential

The biotechnology industry is one of the most important industries in the world.

That’s especially true today as the world is finally starting to come back to normal thanks to the much needed COVID-19 vaccines.

But just because coronavirus has gotten most of the headlines over the last year, that doesn’t mean other diseases and biotechnical problems have stopped happening altogether…

In fact, I feel like they’re being more overlooked now than ever.

That’s why I think investors should be scooping up these top three biotech stocks before Wall Street catches on…

Here they are:

#3 Twist Bioscience Corp. (NASDAQ: TWST)

Founded by two DNA synthesis technologists in 2013, Twist Bioscience Corp. works in medicine, agriculture, industrial chemicals, and data storage to change the world with its proprietary synthetic DNA tools.

finviz dynamic chart for  TWST

The company's mission is to help its customers develop ways to better all life and improve the sustainability of the planet.

And just this week, TWST was been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies (MIC) for 2021.

#2 EXACT Sciences Corp. (NASDAQ: EXAS)

According to its website, Exact Sciences is changing the way we think about detecting and treating cancer. As a leader in cancer testing, the company is committed to providing earlier answers and life-changing treatment guidance.

Shares have experienced steady growth over that last year that I expect to continue into 2022.

Check out its stock chart below:

finviz dynamic chart for  EXAS

The Biggest Drug Ever

Sponsored

In October 2013, a scientist wrote three words down on a piece of paper.

They were simple words. A five-year-old could say them.

But these words hold the key to a new breakthrough the Economist says would be “A boon to humanity.”

And CNBC says, “Would help tens of millions of people.”

He began to tell fellow scientists the three words. And his ideas for them.

He soon recruited a team that's been called “the best scientists on earth.”

Then he started telling investors about them.

In May 2015 Fidelity Biosciences cut him a check for $217 million, along with an investor group.

In August 2016, he told Jeff Bezos the three the words. He walked out with a check for $130 million.

It took just over a year – 390 days – for his company to hit a $1 billion valuation. That's faster than any company in history, including Facebook.

All because of three words. Words that all happen to start with the letter “B.”

Discover the 3 words behind “the biggest drug ever” >>>

How is that possible?

It's because the three words hold the key to a new treatment Jim Cramer says would be “the biggest drug ever.”

A treatment that experts predict could help as many as 50 million people…and save the United States $20 trillion in medical costs.

Any company that harnesses this treatment will thrive.

Which is why a Big Pharma giant bought 11.2% of this small firm's stock last year.
If you follow the lead of Bezos, Fidelity and the Big Pharma giant, you can lock in your stake in this firm today…

And watch three words turn a $1,000 investment into more than $1.1 million.

You have every right to be skeptical…

But when I show you the three words and what they mean…

You'll understand why so many people are rushing to back this visionary entrepreneur…

And why The Wall Street Journal says, “The financial benefits would be massive.”

These three words could do more than just make you rich.

They can change how we treat one of the cruelest diseases on earth.

Discover the 3 words behind “the biggest drug ever” >>>

My #1 Biotech Stock to Own Today…

Steve Cohen, the legendary billionaire stock picker known for delivering huge returns for his clients at SAC Capital – one of the most successful hedge funds ever – is at it again.

But this time, he's doing it with his new company Point72 Asset Management – which manages $17.2 billion for high-net-worth individuals.

Even if us normal folks can’t invest in the Point72 fund itself, we can still copy Cohen’s trades…

You see, Point72 is required to disclose all its holding publicly every quarter.

And last quarter, Cohen’s firm revealed a new position in one penny stock that caught my eye.

Cocrystal Pharma is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses.

finviz dynamic chart for  COCP

The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs.

COCP is currently developing an oral broad-spectrum replication inhibitor called a non-nucleoside inhibitor – which is currently being evaluated in a Phase 2a study for the treatment of hepatitis C as part of an ultra-short therapy of four to six weeks.

Now if you don't know what any of that means, it doesn't matter. All you need to know is that it's huge for the treatment of some of the world's most-killer diseases… and potentially for investors too.

The stock shot up from $0.87 to $2.16 after Cohen announced his stake in the company late last year.

But now that’s it’s down to only $1.14 per share, that makes Cocrystal Pharma one of the more interesting penny stocks to watch for potentially huge gains in 2021.

If those Phase 2 trials turn out successful and the company moves on to Phase 3, the stock should get a boost. And if Phase 3 is successful, the stock could soar.

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Write These Stock Tickers Down Right Now

Enter your email below to see the stock names and tickers on the next page.


By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

ELON’S FINAL MOVE​

Elon’s new AI venture promises to create 10 TIMES MORE American millionaires than Tesla did.
Enter your email below to see the backdoor way to play Musk’s private AI startup…


By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Write These Tickers Down Right Now

Enter your email below to see the stock names and tickers of the 3 REITs Every Retiree Should Target for a “Second Salary” on the next page.


By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

The 3 Titans of AI

Get ready to join the AI revolution! The unstoppable rise of artificial intelligence AI is taking the world by storm, transforming industries and reshaping the future. Excitingly, numerous companies are diving headfirst into this cutting-edge technology, pouring massive investments into AI to revolutionize their products, slash costs, and gain an unbeatable edge over the competition.

But wait, there’s more! Through meticulous research and rigorous analysis, I’ve uncovered the crème de la crème of the AI world. These three mighty AI behemoths are the crown jewels of the market, primed to ride the surging tide of AI adoption across industries.

Imagine the thrill of being part of their phenomenal growth story! Brace yourself for the exciting journey ahead as you invest in these AI Titans—the vanguards of innovation, the masters of AI mastery. They are set to unlock unparalleled opportunities and immense value for savvy investors seeking long-term prosperity.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

The 3 Titans of AI

Get ready to join the AI revolution! The unstoppable rise of artificial intelligence AI is taking the world by storm, transforming industries and reshaping the future. Excitingly, numerous companies are diving headfirst into this cutting-edge technology, pouring massive investments into AI to revolutionize their products, slash costs, and gain an unbeatable edge over the competition.

But wait, there’s more! Through meticulous research and rigorous analysis, I’ve uncovered the crème de la crème of the AI world. These three mighty AI behemoths are the crown jewels of the market, primed to ride the surging tide of AI adoption across industries.

Imagine the thrill of being part of their phenomenal growth story! Brace yourself for the exciting journey ahead as you invest in these AI Titans—the vanguards of innovation, the masters of AI mastery. They are set to unlock unparalleled opportunities and immense value for savvy investors seeking long-term prosperity.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Bill Gates is all about this tiny $2 stock

According to Bill Gates… This company is working on a unique technological innovation that is going to change the world as we know it.

Powerful companies like Microsoft, Intel, and Google are all quietly racing to be at the forefront of this new phenomenon…

But it’s this tiny company who holds the keys to what could be a $7 Trillion Revolution…

Enter your email below for all the details.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Free Access to Chaikin Analytics

Marc Chaikin has developed a system  over the past 50 years…

A website that shows you which stocks could soon rise by 100% or more, by typing in any of 4,000 tickers.

Today, he’s allowing me to offer you free access to the system here, as part of a major new prediction he’s making.

Enter your email for access, and get his free recommendation.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Amazon Price Prediction

Should investors be looking to buy or sell?
Sign up below for our in-depth review & price prediction on Amazon.


By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Apple Price Prediction

Should investors be looking to buy or sell?
Sign up below for our in-depth review & price prediction on Apple.


By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Nvidia Price Prediction

Should investors be looking to buy or sell?
Sign up below for our in-depth review & price prediction on Nvidia.


By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email address to see the name and ticker on the next page.


By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

How to Collect "Amazon Royalty" Payouts Before the Deadline

Thanks to a little-known IRS loophole, regular Americans can collect up to $28,544 (or more) in payouts from what is called “Amazon’s secret royalty program”…
Enter your email address to access all the details.


By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

New "Forever Battery" making gas cars obsolete​

Sign up to get the name of the stock that’s predicted to power every single EV on the planet.


By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

New EV Set to Disrupt Entire Industry

The Wall Street Journal calls it “an American manufacturing triumph.” – Will this disrupt the entire $1.3 trillion EV boom?


By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Tiny TSLA Supplier To Soar

Sign up below for details on Project X and your first FREE report, The #1 EV Stock of 2023 from Market Junkie.


By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Own This Texas Oil Stock Today

Texas Oil Stock to Benefit from Surging Gas Prices. Reveal the ticker by signing up below and you’ll receive ongoing updates from Market Junkie.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

$3.73 EV Stock No One's Talking About

This company is a sneaky EV play that no one’s talking about.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

$30 Stock Freaking Out Billionaires

This stock is an industry leader in a robotics technology that is freaking out billionaires (trading for just $30).

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

The Best TaaS Stock Right Now

This company is set to corner the market in a self-driving technology that  could fundamentally change our entire society – much like the internet did.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Up to 20,000 IPOs All in One Day

A radical $2.1 quadrillion shift is coming to the financial markets.

Some are calling it G.T.E. and Mark Cuban, Elon Musk, Richard Branson, and even banks like J.P. Morgan are invested in the tech behind it.

Just $25 could get you in alongside these billionaires. 

Enter your email address to receive the video that reveals it all.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

53-cent Biotech Stock with $2 Price Target

Steve Cohen, the billionaire stock picker known for running one of the most successful hedge funds ever, has poured millions into the first stock, and it’s trading for only 53 cents.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works